Validation of 24-hour ambulatory gait assessment in Parkinson's disease with simultaneous video observation

Table 1 Patient Characteristics

Subject ID	Gender	Age (yr)	Disease Duration (yr)	Levodopa Dose Equivalency (mg)
006	F	66	12	600
007*	F	77	2	750
011*	M	76	6	700
012*	F	65	12	665

Characteristics of the four Parkinson's disease patients at the time of the study. All four subjects performed the stride length validation. Three patients (denoted by '*' adjacent to subject ID) participated in the 24-h video validation.

ISSN: 1475-925X